HHS gives thumbs down to bluebird’s fertility support programme
The US government will not give bluebird bio the opportunity to offer fertility support to patients covered by federal insurance programmes like Medicaid.
Business & Regulation
Pharma and medtech companies need to team up for wound management
UK clinical trial sector must address prolonged timelines, say experts
EMA endorses AbbVie’s Skyrizi for ulcerative colitis
Swiss biotech ecosystem recuperates from global financial instability
Sanders issues warning to Novo Nordisk amid GLP-1 drug price investigation
Bayer reports drop in Q1 sales amidst patent litigation challenges
Investors anticipate “bounce-back” in European private investment
